1-4 of 4
Constantine Tam, MBBS, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATE TM )

Meletios A. Dimopoulos, MD, Judith Trotman, FRACP, Alessandra Tedeschi, MD, Jeffrey V. Matous, MD, David Macdonald, MD MSc, FRCPC, Constantine Tam, MBBS, MD, Oliver Tournilhac, MD, Shuo Ma, MD PhD, Albert Oriol, MDPhD, Leonard T. Heffner, MD, Chaim Shustik, MD, Ramón García-Sanz, MD PhD, Robert F. Cornell, Carlos Fernández de Larrea, MD PhD, Jorge J. Castillo, MD, Miquel Granell, MD, Marie-Christine Kyrtsonis, MD, Veronique Leblond, MD PhD, Argiris Symeonidis, MD PhD, Priyanka Singh, MS, Jianling Li, MS, Thorsten Graef, MD PhD, Elizabeth Bilotti, MSN, Steven Treon, MD PhD, Christian Buske, MD
Journal: Blood
Blood (2015) 126 (23): 2745.
https://doi.org/10.1182/blood.V126.23.2745.2745
Published: 2015
Journal Articles

Favorable Patient Survival after Failure of Venetoclax (ABT-199/ GDC-0199) Therapy for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Constantine Tam, MBBS, MD, Mary Ann Anderson, MBBS, David S. Ritchie, MDPhD, E. Henry Januszewicz, MBBS, Dennis Carney, Andrew W. Roberts, MBBS, PhD, John F. Seymour, MBBS, PhD
Journal: Blood
Blood (2015) 126 (23): 2939.
https://doi.org/10.1182/blood.V126.23.2939.2939
Published: 2015
Journal Articles

The BTK Inhibitor, Bgb-3111, Is Safe, Tolerable, and Highly Active in Patients with Relapsed/ Refractory B-Cell Malignancies: Initial Report of a Phase 1 First-in-Human Trial

Constantine Tam, MBBS, MD, Andrew P Grigg, MBBS MD, Stephen Opat, MBBS, Matthew Ku, MBBS, Michael Gilbertson, MBBS, Mary Ann Anderson, MBBS, John F. Seymour, MBBS, PhD, David S. Ritchie, MDPhD, Carmen Dicorleto, Belinda Dimovski, Eric Hedrick, Jianxin Yang, Lai Wang, PhD, Lusong Luo, Ling Xue, Andrew W. Roberts, MBBS, PhD
Journal: Blood
Blood (2015) 126 (23): 832.
https://doi.org/10.1182/blood.V126.23.832.832
Published: 2015
Journal Articles

Outcome of Ibrutinib Treatment by Baseline Genetic Features in Patients with Relapsed or Refractory CLL/SLL with del17p in the Resonate-17 Study

Stephan Stilgenbauer, MD, Jeffrey A. Jones, MD MPH, Steven Coutre, MD, Anthony R. Mato, MD MSCE, Peter Hillmen, MB, ChB, PhD, Constantine Tam, MBBS, MD, Anders Osterborg, MD PhD, Tanya Siddiqi, MD, Michael J. Thirman, MD, Richard R. Furman, MD, Osman Ilhan, Michael Keating, MBBS, Timothy G. Call, MD, Jennifer R. Brown, MD PhD, Yunfeng Li, PhD, Karl Eckert, BA, Betty Y. Chang, PhD, Danelle F. James, MD MAS, Alvina D. Chu, MD, Michael Hallek, MD, Susan O'Brien, MD
Journal: Blood
Blood (2015) 126 (23): 833.
https://doi.org/10.1182/blood.V126.23.833.833
Published: 2015